Contributors
STM
THD, ELC, and KLF conceived the study. THD obtained the funding. All authors contributed towards the study design, protocol development, and implementation. DJS, MJN, PM, MN, and JØ contributed to the study planning and clinical design. NF contributed to the study planning and antimicrobial resistance design. THD, ELC, CK, BM, PM, MJN, MN, and KLF contributed to the development of the data collection forms. THD, LC, and BM developed the data management plan. THD, CK, LC, SC, and STM developed and piloted the clinical and laboratory protocols. THD and MJN developed the pharmacy plan and the flow and accountability of treatment allocations and study medications. THD, BM, and LC conducted the data management. THD developed the statistical analysis plan. THD, ELC, BM, and KLF were involved in the analysis. THD, ELC, and KLF were involved in interpreting the data. THD, ELC, and KLF wrote the first draft. All authors read and approved the final manuscript. THD is the guarantor for this work. The corresponding author had full access and verified all data in the study and had final responsibility for the decision to submit.